Subgroup | No. of studies | Heterogeneity | Meta | ||
---|---|---|---|---|---|
I2(%) | Ph | HR(95%CI) | P | ||
CONUT | |||||
Sample size<200 | 82.7 | P = 0.003 | 2.879(1.072–7.731) | P = 0.036 | |
Sample size>200 | 92.4 | P<0.001 | 1.722(1.116–2.659) | P = 0.014 | |
Follow-up duration ≤ 5 years | 0.0 | P = 0.722 | 1.156(1.065–1.254) | P = 0.001 | |
Follow-up duration > 5 years | 83.9 | P<0.001 | 2.712(1.600-4.596) | P<0.001 | |
Cut-off ≤ 3 | 92.2 | P<0.001 | 1.727(1.063–2.806) | P = 0.027 | |
Cut-off>3 | 84.4 | P = 0.002 | 2.741(1.195–6.291) | P = 0.017 | |
Surgery | 94.1 | P<0.001 | 1.719(1.047–2.877) | P = 0.032 | |
Other theory | 75.4 | P = 0.007 | 2.439(1.259–4.726) | P = 0.008 | |
China | 97.9 | P<0.001 | 2.116(0.621–7.207) | P = 0.231 | |
Japan | 72.4 | P = 0.003 | 1.874(1.285–2.733) | P = 0.001 | |
GPS | |||||
Surgery | 31.1 | P = 0.226 | 1.462(1.281–1.669) | P<0.001 | |
Other theory | 67.3 | P = 0.027 | 1.470(1.115–1.940) | P = 0.006 | |
Sample size ≤ 200 | 56.3 | P = 0.076 | 1.693(1.405–2.040) | P<0.001 | |
Sample size>200 | 0.0 | P = 0.440 | 1.323(1.132–1.545) | P<0.001 | |
Cut-off = 1 | 11.9 | P = 0.339 | 1.478(1.302–1.677) | P<0.001 | |
Cut-off = 2 | 86.9 | P = 0.006 | 1.351(0.937–1.950) | P = 0.108 | |
Advanced stage | 62.4 | P = 0.031 | 1.333(1.062–1.673) | P = 0.013 | |
Early stage | 0.0 | P = 0.372 | 1.517(1.318–1.746) | P<0.001 | |
PNI | |||||
Cut-off ≤ 45 | 71.3 | P = 0.001 | 1.740(1.550–1.950) | P<0.001 | |
Cut-off>45 | 0.0 | P = 0.581 | 1.480(1.340–1.630) | P<0.001 | |
Advanced stage | 71.4 | P<0.001 | 1.430(1.170–1.750) | P<0.001 | |
Early stage | 0.0 | P = 0.798 | 1.520(1.340–1.710) | P<0.001 | |
Surgery | 76.3 | P = 0.001 | 1.530(1.170–2.020) | P = 0.002 | |
Other theory | 0.0 | P = 0.713 | 1.450(1.310–1.600) | P<0.001 | |
Sample size ≤ 200 | 0.0 | P = 0.814 | 1.460(1.270–1.670) | P<0.001 | |
Sample size>200 | 75.6 | P<0.001 | 1.490(1.230–1.810) | P<0.001 |